Merck & Co., Inc. is 35.0x more valuable than CORCEPT THERAPEUTICS INC by market capitalization ($293.16 B vs $8.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CORT | MRK |
|---|---|---|
| Market cap | $8.39 B | $293.16 B |
| US-listed rank | #1039 | #44 |
| Revenue (latest FY) | $761.41M | $65.01B |
| Net income (latest FY) | $99.65M | $18.25B |
| Net margin | 13.1% | 28.1% |
| P/E (trailing FY) | 84.2 | 16.1 |
| SEC filings | 1,955 | 996 |
Merck & Co., Inc. is 35.0x more valuable than CORCEPT THERAPEUTICS INC by market capitalization ($293.16 B vs $8.39 B).
In their latest fiscal years, CORCEPT THERAPEUTICS INC reported $761.41M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: CORCEPT THERAPEUTICS INC and Merck & Co., Inc., or browse the full rankings.